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Analysis of increased myocardial contractility during sodium acetate
infusion in humans. To analyze the reported effects of acetate on left
ventricular (LV) contractility during dialysis, LV function was studied
before and after a 20-mm sodium acetate (Na Ac) infusion (0.06
mmoles kg min') in seven patients with heart rate (HR) con-
trolled by atrial pacing. Angiographically determined LV volumes and
LV pressures were used to calculate the LV function indices. A plasma
acetate concentration of 3.13 1.05 (SD) mmoles liter induced an
increase in cardiac index from 3.8 0.6 to 4.4 0.6 (SD)
liter• min' m2 (P < 0.01) and a rise in total body 02 consumption
from 7.47 1.28 to 8.67 1.66 mmoles min ' m 2 (P <0.05); there
was no alteration of the volume elastic constant, of the end diastolic
stress, and of the end systolic stress. There was an increase of the
ejection fraction from 0.44 0.10 to 0.51 0.09 (P < 0.01). the
maximum velocity of shortening (Vmax, sec) from 1.37 0.25 to 1.55
0.28 (P < 0.05), and of the end systolic stress—end systolic volume
ratio (g cm2 mL') from 2.99 0.76 to 3.40 0.98 (P < 0.01).
Hence, the enhancement of these indices was not the consequence of
any alteration of HR, preload, or afterload. In seven other subjects,
HR, LV end diastolic and systolic pressures, positive dP/dtmax, and
Vn,a. were measured before, during, and after a 6-mm infusion of Na Ac
into the left coronary artery (0.45 mmoles min I); none of these
parameters varied significantly during the procedure. It is concluded
that the enhancement of myocardial contractility by acetate did not
result from a direct effect of acetate on myocardium, but was more
likely mediated by an increased peripheral metabolism.
Etude de l'augmentation de Ia contractilité myocardique par l'acétate
chez les hommes. Afin d'analyser les effets de l'acétate sur Ia
contractilité du ventricule gauche (VG), Ia fonction VG a étë ëtudiée
avant et après 20-mm de perfusion d'acétate de sodium (Na Ac) (0,06
mmoles kg min) chez sept sujets dont La fréquence cardiaque(FC) était contrOlëe par stimulation auriculaire. Les volumes VG
calculés par angiographie et les pressions VG ont été utilisës pour
calculer les indices de fonction ventriculaire gauche. Une concentration
plasmatique d'acétate de 3,13 1,05 mmoles litre a entrainé one
augmentation de l'index cardiaque de 3,8 0,6 a 4,4 0,6 (SD)litre min m 2 (P < 0,01) et une élévation de Ia consommation
doxygène de 7,47 1.28 a 8,67 1,66 mmoles mm1 m2 (P <
0,05): il ny a pas eu de modification de Ia constante d'élasticité
volumique, de Ia contrainte télédiastolique et de Ia contrainte
telesystolique. La fraction dejection s'est élevée de 0,44 0,10 a 0,51
0,09 (P < 0,01), Ia vitesse maximum de raccourcissement (V,,,ax,
sec) s'est élevée de 1.37 0,25 a 1,55 0,28 (P <0,05), Ic rapport
contrainte-volume telesystolique (g cm2 ml ') s'est ClevC de 2,99
0,76 a 3,40 0,98 (P < 0,01). L'augmentation de tous ces indices ne
rCsultait done pas de modifications de Ia FC, de La pre-charge ou de Ia
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post-charge. Chez sept autres sujets, Ia FC, Ia pression telédiastolique
et de Ia pression systolique du VG, Ia dP/dta, et Ia Vma,, oflt été
mesurés avant, pendant et après une injection continue d'acétate de
sodium pendant 6-mm dans l'artère coronaire gauche (0,45
mmoles min I); aucun des paramétres n'a vane de facon significative
lors de cc protocole. Ii apparaIt done que l'augmentation de Ia
contractilité myocardique induite par l'acétate ne résulte pas dun effet
direct de l'acCtate sur Ic myocarde, mais qu'elle est plus probablement
secondaire a une élévation du métabolisme périphérique.
Sodium acetate is currently used in the preparation of the
dialysate for hemodialysis. Cardiovascular instability with se-
vere hypotension has been reported in patients during
hemodialysis with sodium acetate [1, 21. In addition to
hypovolemia and its consequences on left ventricular preload
[3, 41, two mechanisms were suspected to induce hypotension:
(1) acetate-dependent depression of sympathetic activity and its
consequences on blood pressure regulation [3] and (2)
myocardial negative inotropic effect of acetate [5—8]. However,
the latter effect has been contested and a positive inotropic
effect has been reported in patients submitted to sodium acetate
hemodialysis [9—12]. These discrepancies concerning the effects
of acetate on myocardial contractility may result from the fact
that the currently used indices of myocardial contractility
depend on preload, afterload, and heart rate alterations [13].
This study was undertaken to determine the effect on left
ventricular contractility of an acute plasma elevation of acetate
concentration, comparable to that induced at the beginning of a
hemodialysis session with sodium acetate, when heart rate is
controlled by atrial pacing, and when left ventricular preload
and afterload are considered.
Methods
Protocol I
Patient selection. Seven male patients undergoing cardiac
catheterization for stable coronary artery disease (Class 2 and
Class 3 NYHA) and without left ventricular failure or valvular
dysfunction were selected for the study of the effects of a
sodium acetate infusion on left ventricular contractility. In-
formed consent was obtained after the nature and risk of the
study had been explained to each patient. Patients with cardiac
arrhythmias and valvular dysfunction were excluded from the
study. All cardiac drugs were discontinued 48 hr before the
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Table 1. Angiographic data of the patients (unpaired t test for EDV
and EF comparison)
Left ventricular
angiography
EDV EF
Patients ml m2 %
Protocol 1
71 62
2 85 33
3 91 37
4 112 41
5 104 41
6 113 50
7 113 45
Mean SD 98 17 44 10
investigation. All patients had fasted for more than 12 hr and
none were premedicated. Ages ranged from 48 to 58 yr (54 4
yr, mean SD) and body weight was 71 11 kg (mean SD).
Results of left ventricular and coronary angiography are listed
in Table 1. Measurements were made before sodium ace-
tate venous infusion at a constant rate of 0.06
mmoles kg min (acetate concentration of the solution,
1.60 mmoles m1 1), and 20 mm after the beginning of the
infusion, when arterial concentrations of acetate comparable to
those obtained in patients undergoing a hemodialysis session
[14, 151 were reached. Each patient was his/her own control.
Catheterization procedure. Using 1% lidocaine as a local
anesthesia, left and right heart catheterizations were performed
percutaneously. To achieve atrial pacing and pulmonary artery
blood sampling, a 5F bipolar electrode catheter and a 7F
catheter were positioned via a femoral vein into the right atrium
and pulmonary artery, respectively. A 7F high fidelity double-
tipped micromanometer catheter (PC 770, Millar Instruments)
was placed into the left ventricule (LV) through a femoral artery
and positioned to record left ventricular and aortic pressure
simultaneously. A 8F pig tail angiographic catheter (Cordis
Laboratory) was positioned into the LV via the other femoral
artery.
Method. After the catheters were positioned, and after heart
rate (HR) and blood pressure returned to precatheterization
levels, atrial pacing was started at 120% of the basal rate.
Control blood sampling was achieved 5 mm after atrial pacing
began and a first left ventriculography (1 ml kg' ioxaglate;
580 mOsm . kg—'; Na, 0.145 mmoles . m1') was realized in a
30 right anterior oblique incidence (100 frames . sec') with
simultaneous recording of LV pressure, aortic pressure, and
Heart rate, beats
min' 90 10
Mean aortic pressure,
mm Hg (kPa)
109 23
(14.5 3.1)
117 13
(15.6 1.7)
NS
80
50
Left ventricular
systolic pressure,
mmHg (kPa)
141 36
(18.8 4.8)
152 22
(20.2 2.9)
NS
60
Left ventricular
end diastolic pres-
sure, mm Hg (kPa)
15 11
(2.0 1.5)
15 7
(2.0 0.9)
NS
97 NS
47 12 <0.05
50 10 <0.01
Cardiac output,liter nun' m 3.8 0.6 4.4
0.6 <0.01
Systemic vascular
resistances, mm
Hg liter' mm
(kPa . 1iter . mm)
15.7 4.1
(2.1 0.5)
14.3 2.7
(1.9 0.4)
NS
exposed frame marker (paper speed, 100 mm sec'). Ten
minutes after angiography, the venous infusion of sodium
acetate was started. Twenty minutes after the acetate infusion
began, that is, 30 mm after the first angiography to avoid the
hemodynamic effects of contrast material [16], blood sampling
and hemodynamic measurements were repeated before the
obtention of a second LV angiography in the same position.
Data analysis and calculations. Pressure recordings were
introduced in a catheterization data analysis computer system
(Hewlett Packard 5600 M) which performed an on-line analysis
of LV and aortic pressures on nine beats for averaging out
respiratory variations. The computer calculated left ventricular
end diastolic pressure (LVEDP), left ventricular systolic pres-
sure (LVSP), mean aortic pressure (MAP), left ventricular
positive dP/dtmax (+ dP/dtmax), and maximum velocity of short-
ening (Vmax). Left ventricular end diastolic volume (LVEDV)
and end systolic volume (LVESV) were calculated using the
area length method [17]. Cardiac output (CO) was obtained by
multiplying left ventricular stroke volume (LVSV) and heart
rate. Systemic vascular resistances (SVR) were calculated as
MAP/CO. Left ventricular end diastolic and end systolic wall
thicknesses were calculated on ventriculograms (Appendix A)
and allowed to calculate left ventricular end diastolic and end
systolic wall stress (Appendix B). Left ventricular systolic
performance was assessed through systolic pump function
indices [ejection fraction (EF) was calculated as
LVSV/LVEDV, and left ventricular stroke work (LVSW) was
Left ventricular 98 17
end diastolic vol-
50 ume, ml m2
Left ventricular 56 13
70 end systolic vol-
ume, m1 m2
Coronary artenography
(% stenosis)
Table 2. Hemodynamic and angiographic data (mean SD, N = 7)
LAD CIRC LMA DA RCA
Control Na acetate P
40
60
50
60
70
30
50
50
40
70
70
70
50
50
30
40
Protocol 2
2
3
4
5
6
7
Mean 5D
P (Protocol 1
74
103
126
86
82
99
88
94 17
NS
60
45
38
40
55
39
51
47 9
NS
vs. Protocol 2)
30
50 Left ventricular 43 10
stroke volume,
ml m2
Abbreviations: EDV, end diastolic volume; EF, ejection fraction;
LAD, left anterior descending artery; CIRC, circumflex artery; LMA,
left marginal artery; DA, diagonal artery; RCA, right coronary artery.
Stroke work index
P<0.O5 "P<0.01
Fig. 1. Left ventricular pump function indices (mean sEM). Abbrevia-
tions used are: C, control data; Na Ac, sodium acetate data.
calculated as LVSV times mean LV systolic pressure], and
myocardial contractility indices (Vma,, [18] and end systolic
stress—end systolic volume ratio [19]). Left ventricular relaxa-
tion was assessed by peak negative dP/dt and relaxation time
constant T calculated according to the method of Weiss et al
[20], assuming an exponential relaxation period. Left ven-
tricular compliance was assessed by the volume elastic constant
a 121], and myocardial stiffness was evaluated by the elastic
stiffness constant k [22].
Mixed venous and arterial 02 contents were measured by a
galvanic cell method (Lex 02 ConK, Waltham Instruments).
Arterial and mixed venous blood pH, Pco2 and PD2 were
measured with an ABL II blood gas analyzer (Radiometer).
Whole body oxygen consumption (V02) was calculated by
multiplying arterial minus mixed venous blood 02 contents
difference (a — t'02D) and CO. Plasma acetate concentration
was determined by an enzymatic technique (Boehringer Man-
nheim): acetate was converted to acetyl CoA in the presence of
acetyl CoA synthetase, ATP, and coenzyme A. The determina-
tion was based on the formation of NADH evaluated by the
increase in absorbance at 334 nm. Serum ionized calcium
concentration was measured with a specific electrode calcium
analyzer (Orion Research Inc.).
Statistical methods. Mean values, standard deviation (SD),
and standard error of the mean (sEM) were calculated for each
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C Na AcC NaAc
0.55—
0.50—
0.45—
0.40—
Ejection fraction
C NaAc
End diastolic stress
E
70— —7
60—
—6
5
a.
50—
—5
40— —4
C NaAc
0.022..-. NS
0.020— i__I
E
0.018—
.1
0.016—
Volume elastic constant
C NaAc
18—
NS
T17-
16-
15—
Elastic stiffness constant
Fig. 2. Diastolic properties of the left ventricle (mean SEM). Ab-
breviations used are: C, control data; Na Ac, sodium acetate data.
parameter. Differences between sodium acetate infusion and
control data were examined using the paired t test. Significance
was considered present if the value was P < 0.05. Abbrevia-
tions used are: C, control data; NaA, sodium acetate data.
Protocol 2
A second group of seven patients without left ventricular
failure or valvular dysfunction [three female and four male; age
54 9 (SD); weight 71 18 kg (SD)] investigated for coronary
disease (Class 2 and Class 3 NYHA) was submitted to the
following procedure: A 0.45 mmoles mm - infusion of sodium
acetate was achieved into the left coronary artery for 6 mm (left
ventricular and coronary angiography data are listed in Table
1). The acetate concentration of the solution was 0.34
mmoles m11 and the rate of infusion was 1.33 ml min1.
Assuming a coronary blood flow of 150 ml min, the infusion
must have induced a left coronary plasma acetate concentration
of 5 mmoles liter Left ventricular pressure was recorded by
a 7F micromanometer tipped catheter (Millar Instruments).
Left ventricular systolic pressure, LVEDP, + dPldtmax, Vmax,
and HR were recorded or calculated before sodium acetate
infusion, 2, 3, 4, 5, and 6 mm after the infusion began and 3 mm
after infusion. All values were automatically averaged on nine
cycles by the computer system.
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320-
300-
à 280-
260-
End systolic stress
C NaAc
3.8-
-0.37
3.6—
—0.35
-
.8
—0.27
2.6-
End systolic stress/End systolic volume
1700-
1600-
1500-
E 1400-
E 1300-
C NaAc
- 230
-210
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340-
C NaAc
-34
-30
-26
Peak positive dP/dt
C NaAc
1.70- *
1.60- T
1.30- 1
Vmax
P<0.05 P<0.01
Fig. 3. Left ventricular contractility indices
(mean 5EM). Abbreviations used are: C,
control data; Na Ac, sodium acetate data.
—260
Mean values and SD were calculated. Data were examined
using analysis of variance. Significance was considered present
c Na Ac2000 —
if we had a value of P < 0.05.
1900—
u 1800—
—240
1700—
E —220
1600—
.1
Results
Protocoll
Plasma acetate concentration at 20 mm (Table 2) was corn-
parable to values found in patients undergoing a hemodialysis
session performed with an acetate dialysate [14, 15].
1500 —200 Hemodynamic and angiographic data are summarized in
.Peak negative dP/dt Table 2: LVSP, LVEDP and MAP were not significantlydifferent between acetate and control. Left ventricular stroke
volume was significantly increased during acetate infusion; this
elevation resulted from a reduction of LVESV, without any
alteration of LVEDV. There was then a significant increase in
both EF, and LVSW (Fig. 1). Cardiac output, calculated from
LVSV and the imposed HR, was significantly increased during
c Na Ac
acetate infusion. The SVR were not significantly affected.
LVEDV and LVEDP were not altered by acetate infusion; the
42— T LV end diastolic stress did not vary (Fig. 2). The absence of
variation of the volume elastic constant a, as well as of the
40— elastic stiffness constant k, indicated that left ventricular corn-
38—
I36- T
I34-
I32-
pliance and myocardial stiffness were not altered by acetate
infusion (Fig. 2). Contractility indices, that is, Vmax and end
systolic stress—LVESV ratio (0-ES/LVESV) (Fig. 3), and indices
of relaxation (peak negative dP/dt and T) were significantly
improved during acetate infusion (Fig. 4). Preload, estimated by
end diastolic stress, and afterload, estimated by end systolic
stress [231, were not significantly altered (Figs. 2 and 3).
Blood and plasma data (Table 3). Arterial P02 and Pco2 were
not significantly altered by sodium acetate infusion. Arteri-
ovenous oxygen difference did not vary significantly: 1.98
Relaxation time constant 036 rnmoles liter (control) versus 1.97 0.41
P<o.os P<0.01 mmoles liter (sodium acetate). Thus, the increase in V02
Fig. 4. Left ventricular relaxation indices (mean SEM). Abbreviations
used are: C, control data; Na Ac, sodium acetate data.
(from 7.47 1.28 to 8.67 1.66 mmoles min m P <
0.05) was proportional to the increase in CO. Arterial pH and
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Table 3. Blood and plasma data (mean SD, N = 7)
Control Na acetate P
Acetate, mmoles liter' 0.016 10 3.13 1.05 <0.001
P02, mm Hg, kPa 75.0
(10.00
9.8
1.30)
73.2
(9.76
12.9
1.72)
NS
Pco2, mm Hg, kFa 37.2
(4.96
4.00
0.53)
34.4
(4.58
7.13
0.95)
NS
pH 7.40 0.02 7.48 0.05 <0.01
HCO3, mmoles - liter' 22.83 1.91 25.09 2.13 <0.001
Ca2*, mEq . liter° 2.04 0.17 1.90 0.16 <0.001
Sodium, mmoles liter' 135.7 3.3 139.4 3.1 <0.001
Potassium, mmoles liter° 3.7 0.2 3.6 0.2 NS
Protein, g- liter' 61.9 4.0 61.6 6.6 NS
Hematocrit, % 40.6 3.4 40.9 4.6 NS
T; EF '
E { f4——1—f——f
100
U
1600
T14OO
J TJ J I ___: vtrn
800
HH+H
Time, , ,
mm
Fig. 5. Evolution of heart rate (HR), left ventricular systolic pressure
(LVSP), left ventricular end diastolic pressure (LVEDP), left ven-
tricular positive dPldtmax, and maximum velocity of shortening (Vmax)
during a direct infusion of sodium acetate into the left coronary artery.
Abbreviations used are: , control values; t1 to t5, values recorded 2, 3,
4, 5, and 6 mm, respectively, after sodium acetate infusion began; t6,
values recorded 3 mm after sodium acetate infusion.
Table 4. Animal studies of the effect of acetate on myocardial
contractility
HC03 plasma concentration were both significantly increased
by sodium acetate infusion. Serum ionized calcium decreased in
each patient. Potassium concentration was not altered and
sodium concentration was significantly risen. Protein concen-
tration and arterial hematocrit did not evidence any alteration
between control values and sodium acetate infusion values.
Protocol 2
Direct infusion of sodium acetate into the left coronary artery
did not induce any detectable alteration of HR, LVEDP, and
LVSP, + dP/dtmax, and 'max (Fig. 5). Preinfusion data, as well
as values recorded 3 mm after infusion, were not significant-
ly different from the values obtained during sodium acetate
infusion.
Discussion
Experimental studies in animals (Table 4) as well as previous
data in humans (Table 5) have led to conflicting conclusions
concerning the effect of acetate on LV myocardial contractility.
The discrepancies observed in human results are likely to be
explained by the difficulties of myocardial contractile state
assessment during a clinical investigation: (1) the currently used
indices either are not, or at best are, rather rough, contractility
indices; (2) all the left ventricular function indices more or less
depend on variations of heart rate, preload, and afterload [13];
and (3) the parameters used as estimates of preload and
afterload are unreliable.
The present study evidenced an enhancement of both
systolic pump and LV contractility indices, resulting from a
positive inotropic effect, in patients with plasma acetate con-
centration comparable to that found during sodium acetate
hemodialysis. This increased myocardial contractility is best
estimated by a crES/LVESV ratio [19, 27] and did not result from
an alteration of the three factors which could affect myocardial
contractility, that is, heart rate, preload, and afterload, which
did not vary significantly. Moreover, the enhancement of LV
relaxation indices strengthens the hypothesis that acetate im-
proved the myocardial function since relaxation has been
recently considered as part of the systolic function [28].
That the positive inotropic effect that is observed is a
consequence of the high plasma acetate concentration and not
of an unrelated concomitant alteration is likely: (1) A blood
volume increase [131 elicited by contrast medium injection can
be excluded since it has been shown that the relatively low
Sodium acetate
0 +2 +3 +4 +5 +6
to ti t2 t3 t4 to
+9
to
Authors Material Myocardial contractility
Liang and Lowenstein [4] Anesthetized and
awake dog
Enhanced
Kirkendol et at [6] Rabbit papillary
muscle
Depressed
Kirkendol et al [6] Anesthetized dog Transiently depressed
Kirkendol et al [24] Anesthetized dog Enhanced
Anderson and Foulks [7] Frog ventricular
myocardium
Transiently depressed
Williamson [25] Isolated perfused
rat heart
Unchanged
James and Bear [26] Anesthetized dog Unchanged
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Table 5. Human studies of the effect of acetate on myocardial contractility during acetate hemodialysis in acute or chronic renal insufficiency;
the alteration of the three parameters which could modify the left ventricular contractility and the mean by which preload and afterload were
evaluated are indicated
Authors Indices Preload Afterload Heart rate
Left ventricular
contractility
Aizawa et a! [5] PET/ET
(phonocardiography and
carotid pulse curve)
Unknown Reduced
(MAP)
Unchanged Depressed
Vincent et al [81 LVSW, LVSV
(pressures and thermo-
Reduced
(PWP)
Reduced
(MAP)
Increased Depressed
O'Regan et al [9]
dilution CO)
EF, VCF Reduced Unchanged Increased Enhanced
Chaignon et al [10]
(echocardiography)
VCF, EF, MSER
(echocardiography)
(LVEDV)
Reduced
(LVEDV)
(SVR)
Reduced
(SBP)
Unchanged Enhanced
Cmi et al [11] EF Reduced Increased Unchanged Enhanced
Nixon et al [12]
(echocardiography)
EF, VCF
(echocardiography)
(LVEDV)
Unchanged
(LVEDV)
(MAP, SVR, SBP)
Unchanged
(MAP)
Unchanged Enhanced
Abbreviations: PET, pre-ejection time; ET, ejection time; LVSW, left ventricular stroke work; LVSV, left ventricular stroke volume; CO,
cardiac output; EF, ejection fraction; VCF, mean velocity of circumferential fiber shortening; MSER, mean systolic ejection rate; MAP, mean
arterial pressure; PWP, pulmonary wedge pressure; LVEDV, left ventricular end diastolic volume; SVR, systemic vascular resistances; SBP,
systolic blood pressure.
osmolality of ioxaglate only resulted in a 5% increase of plasma
volume 30 mm after injections in the range of 1 ml kg' [29];
osmolality of ioxaglate only resulted in a 5% increase of plasma
volume 30 mm after injections in the range of 1 ml kg [29];
moreover, the absence of any alteration of LV preload (Fig. 2),
arterial hematocrit, and plasma protein concentration (Table 3)
agrees with the absence of blood volume increase during
acetate infusion; (2) the small increase in plasma osmolality
[30], which must have occurred as a consequence of the
infusion of hypertonic sodium acetate (2.4 mOsm kg ')and of
hypertonic contrast medium (1.16 mOsm kg 1), is not likely to
account for the positive inotropic effect since it has been shown
that hyperosmolality due to pyruvate infusion did not—while
acetate infusion did—elicit a positive inotropic effect [4].
The acetate infusion was the determinant of a metabolic
alkalosis, which, in turn, was responsible for the decrease of
ionized plasma calcium concentration. Metabolic alkalosis was
reported to induce a positive inotropic effect [31—34] through an
increased binding of catecholamines on myocardial cell recep-
tors [35]. Since the binding reached its maximum at pH 7.40
[35], which was the control arterial blood pH value in Protocol
1, such a role of metabolic alkalosis in this study is unlikely.
Neither is a role of the decreased ionized plasma calcium
concentration, a decrease which, on the contrary, could have
had a negative inotropic effect [36].
Finally, this study does not elucidate the mechanism by
which sodium acetate induces a positive inotropic effect. The
effect is not a direct one, that is, the consequence of a high
plasma acetate concentration in the blood irrigating the
myocardium, because the intracoronary infusion which must
have resulted in the same, or even higher, acetate concentration
in the left coronary artery blood, did not improve contractility.
This result is in line with the absence of acetate-induced
increase in oxygen consumption by the isolated rat heart [37,
38]. A sympathetic response to a peripheric acetate-induced
vasodilation has been proposed to account for the increased
myocardial contractility [24]. This hypothesis, however, is not
supported by (1) the fact that propranolol did not prevent the
positive inotropic effect of sodium acetate infusion [4]; (2) the
lack of increase in plasma norepinephrine concentration during
acetate hemodialysis [39]; and (3) the lack of evidence of
vasodilation in the present study since SVR and MAP did not
vary significantly during sodium acetate infusion in Protocol 1.
A neurogenic pathway, initiated by peripheral metabolic
changes induced by acetate and acting on peripheral receptors
[40] could be involved. The significant increase in total body
oxygen consumption observed during sodium acetate infusion
in the present study may be the consequence of such peripheral
metabolic changes.
Enhancement of LV contractility during sodium acetate
infusion is clearly demonstrated by this work performed at
constant heart rate and without significant variation of preload
and afterload. The results suggest that hypotension during
hemodialysis with sodium acetate is not due to an acetate-
induced myocardial negative inotropic effect and that the en-
hancement of contractility does not result from a direct effect of
acetate on the myocardium. The mechanism by which this
effect was mediated may originate in an increased peripheral
metabolism, but the sequence remains unclear. Extrapolation
of these results to patients with acute or chronic renal failure
beyond a period of 30 mm should be performed with care since
in the present study the enhancement of myocardial contractil-
ity during acetate infusion was only evidenced on nonuremic
patients with coronary artery disease during an acute elevation
of plasma acetate concentration.
Appendix A: Calculation of left ventricular wall thickness
Left ventricular wall thickness was measured at end diastole
at the equator of the LV on the first angiography (hm). Actual
wall thickness at end diastole (haD) was calculated after correc-
tion for x-ray image distortion by filming a calibrated grid at the
assumed location of the LV; the ratio of true length on the grid
to the measured length corresponding to it on the film was the
correction factor (CF). The actual thickness was obtained by
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the equation following:
hED (cm) = hm (cm) x CF
The value of hED was used to calculate the left ventricular
myocardial wall volume (Vw) according to the Trenouth,
Phelps, and Neill equation [41]:
Vw (ml) =
(4/3)1r[(LED + hED)/2][(DED/2) + hED]2 — LVEDV (ml)
where LED (cm) is the major axis of the LV at end diastole
(measured major axis on the angiography corrected by the
correction factor) and DED (cm) is the minor calculated axis of
the LV at end diastole, derived from the LVEDV calculated by
the area-length method [17]: DED = (V3LVEDV/4IrLED). The
left ventricular myocardial wall volume was then assumed to
be constant and its value was used to calculate, with the
Trenouth, Phelps, and Neill equation [41), acetate end dia-
stolic wall thickness and basal and acetate end systolic wall
thicknesses.
Appendix B: Calculation of left ventricular wall stress
Average left ventricular equatorial wall stress o(g cm2)
was calculated using the Falsetti et al equation [42] for an
ellipsoidal geometry of the LV:
a- = (Pb/h) [(2a2 — b2)/(2a2 + bh)]
where P (mm Hg) is the intraventricular pressure, a (cm) is the
major semiaxis (L/2), b (cm) is the minor semiaxis (D/2), and h
(cm) is the wall thickness.
End diastolic stress (a-ED) was calculated using the LV
volume corresponding to the LVEDP; end systolic stress (a-)
was calculated using the LV pressure corresponding to the LV
smallest volume.
Reprint requests to Dr. A. Nitenberg, CHU Xavier Bichat, 46, rue
Henri Huchard, 75877 Paris Cedex 18, France
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